Query Result Set
Skip Navigation Links
   ActiveUsers:1414Hits:19147454Skip Navigation Links
Show My Basket
Contact Us
IDSA Web Site
Ask Us
Today's News
HelpExpand Help
Advanced search

  Hide Options
Sort Order Items / Page
FAUNCE, THOMAS (2) answer(s).
 
SrlItem
1
ID:   140725


Australia's embrace of investor state dispute settlement: a challenge to the social contract ideal? / Faunce, Thomas   Article
Faunce, Thomas Article
0 Rating(s) & 0 Review(s)
Summary/Abstract This paper explores the origins of investor-state dispute settlement (ISDS) treaties and their implications for the Australian social contract. This analysis includes how and why ISDS emerged in NAFTA, was rebuffed with the failure of the Multilateral Agreement on Investment (MAI), and became incorporated into most subsequent bilateral US trade and investment agreements. The paper considers Australia's exposure to ISDS—first through using it in bilateral investment agreements in nations with inadequate governance mechanisms to support the rule of law, then turning against it when a multinational tobacco company tried to use the mechanism to overturn scientifically endorsed, democratically approved and constitutionally validated tobacco plain packaging measures. The paper concludes by exploring the hypothesis that an alternative governance vision can be achieved in which the system of investment arbitration and trade law is made coherent with presumptively more democratically legitimate normative systems such as constitutional and international law.
        Export Export
2
ID:   082368


Bilateral trade agreements as drivers of national and transnati: implications of recent US deals for Australian negotiations with China and India / Faunce, Thomas; Shats, Kathy   Journal Article
Faunce, Thomas Journal Article
0 Rating(s) & 0 Review(s)
Publication 2008.
Summary/Abstract This article compares controversial health technology provisions in two important United States free trade agreements with developed nations: Australia and with South Korea. It examines the multinational corporate forces behind the medicines and medical devices components of these texts and their likely impacts upon Australian trade negotiations with China and India. It also examines the implications of some recent changes to US trade policy for this area in subsequent bilateral deals such as that with Peru. This article argues it is important that the Australian government change policy and, like the present Congress in the United States, now systematically approach such impending trade agreements with a view to assisting the partners' regulatory frameworks to maximally enhance national and transnational benefit from their medicines and biotechnology industries
Key Words Australia  China  India  Negotiation  Trade Policy  Bilateral Trade Agreements 
        Export Export